Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Durable Responses and Cystectomy Avoidance with IL-15 Receptor Agonist NAI plus BCG In BCG-Unresponsive NMIBC with Carcinoma In Situ +/- Papillary Disease.
Journal: The Journal of urology
Published: July 06, 2026
12-Month Outcomes From a Randomized, Sham-Controlled Trial Evaluating a Novel Prostatic Urethral Stent for the Treatment of Benign Prostatic Hyperplasia.
Journal: The Journal of urology
Published: December 15, 2025
Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer.
Journal: The Journal of urology
Published: September 16, 2025
The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Journal: The Journal of urology
Published: August 09, 2023
Management of female stress urinary incontinence with single-incision mini-sling (Altis®): 36 month multicenter outcomes.
Journal: Neurourology and urodynamics
Published: April 17, 2023
IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer.
Journal: NEJM evidence
Published: January 01, 2023
Hereditary cancer risk assessment and genetic testing in the community urology practice setting.
Journal: The Prostate
Published: November 15, 2021
Last Updated: 09/26/2026